サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1561444

マイクロキャリア市場レポート：製品、材料タイプ、用途、エンドユーザー、地域別、2024年～2032年

Microcarrier Market Report by Product, Material Type, Application, End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロキャリア市場レポート：製品、材料タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマイクロキャリア市場の市場規模は2023年に17億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに26億米ドルに達し、2024年から2032年の間に5.2％の成長率（CAGR）を示すと予測しています。世界市場は主に、バイオ医薬品に対する需要の高まり、細胞ベースの治療法における継続的な進歩、幹細胞研究の拡大、キャリア設計における継続的な技術革新、バイオ製造インフラへの多額の投資によって牽引されています。

マイクロキャリア市場分析：

  • 市場の成長と規模：世界市場は、バイオ医薬品と細胞ベースの治療に対する需要の増加に牽引されて力強い成長を遂げており、その結果、市場規模は大きくなっています。
  • 主な市場促進要因：主な市場牽引要因：バイオ医薬品需要の増加、細胞ベースの治療法の進歩、幹細胞研究の拡大などが挙げられます。
  • 技術の進歩：設計および製造技術における新たなイノベーションにより、表面特性、サイズ、形状が改善され、細胞培養プロセスが強化され、製造コストが削減されています。
  • 産業への応用：ワクチン製造や細胞治療に幅広く応用され、バイオ医薬品業界におけるこれらの重要な分野の成長を支えています。
  • 主要市場動向：主な動向としては、バイオ製造におけるシングルユース技術の採用、バイオ医薬品ハブとしてのアジア太平洋地域の台頭、適応性の高さによるアルギン酸塩ベースのバリアントへの選好などが挙げられます。
  • 地理的動向：北米はバイオ医薬品産業が確立されているため依然として最大市場であるが、アジア太平洋地域はバイオテクノロジー・インフラへの投資により急速な成長を遂げています。
  • 競合情勢：主要企業は研究開発への投資、生産能力の拡大、戦略的パートナーシップの形成、市場競争力を維持するための規制遵守に注力しています。
  • 課題と機会：課題には、規制の複雑さや一貫した品質管理の必要性などがあります。機会は、バイオ医薬品に対する世界の需要の高まりとバイオ製造インフラの拡大にあります。

マイクロキャリア市場動向：

バイオ医薬品の需要拡大

バイオ医薬品は、さまざまな疾患の治療に有効であることから脚光を浴びており、こうしたバイオ医薬品の製造において極めて重要な役割を果たしています。製薬業界が生物製剤と個別化医療にシフトし続ける中、バイオプロセスにおける細胞培養用基板としてのマイクロキャリアの需要は増加すると予想されます。この要因は、キャリアが促進するスケーラブルで効率的な細胞拡大・培養プロセスの必要性による。バイオ医薬品分野における研究開発の継続的な取り組みとバイオ製造施設の拡大が、市場の持続的成長に寄与しています。さらに、COVID-19パンデミックはワクチンや治療用タンパク質の需要をさらに加速させ、バイオ製造における重要な役割を強調しています。

細胞ベースの治療法の進歩

細胞ベースの療法、特に再生医療と免疫療法の急速な進歩が市場の成長を促進しています。これらの治療法では、患者由来の細胞や免疫細胞の培養・増殖が行われるため、細胞増殖のための支持マトリックスとしての使用が必要となります。個別化医療への注目の高まりや、がん、自己免疫疾患、組織再生といった疾患に対する革新的な治療法の開発が、需要の高まりにつながっています。加えて、細胞培養システムが提供する柔軟性、拡張性、再現性により、細胞療法の製造に不可欠なものとなっており、市場の見通しをポジティブなものにしています。

幹細胞研究の拡大

幹細胞研究は、基礎研究と臨床応用の両方に応用されるダイナミックで有望な分野であり続けています。幹細胞は、発生過程の研究であれ、治療目的であれ、幹細胞の増殖に広く利用されています。これに加えて、再生医療への関心の高まりと相まって、幹細胞研究への投資が増加していることが、世界中の市場を後押ししています。研究者やバイオテクノロジー企業は、細胞ベースの治療法や組織工学の開発に不可欠な幹細胞の増殖と分化のための制御された環境を提供するために、マイクロキャリアに依存しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のマイクロキャリア市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 装置
    • 市場動向
    • 主要セグメント
      • バイオリアクター
      • 培養容器
      • 濾過システム
      • 細胞カウンター
      • アクセサリー
    • 市場予測
  • 消耗品
    • 市場動向
    • 主要セグメント
      • メディア
      • 試薬
      • マイクロキャリアビーズ
    • 市場予測

第7章 市場内訳：材料タイプ別

  • アルギン酸ベース
    • 市場動向
    • 市場予測
  • コラーゲンベース
    • 市場動向
    • 市場予測
  • デキストランベース
    • 市場動向
    • 市場予測
  • ポリスチレンベース
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • ワクチン製造
    • 市場動向
    • 市場予測
  • 細胞療法
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • 学術研究機関
    • 市場動向
    • 市場予測
  • 受託研究機関（CRO）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • CESCO Bioengineering Co. Ltd.
    • ChemoMetec A/S
    • Corning Incorporated
    • Cytiva（Danaher Corporation）
    • Eppendorf AG
    • Esco VacciXcell
    • HiMedia Laboratories
    • Lonza Group AG
    • Merck KGaA
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • VWR International LLC（Avantor Inc.）
図表

List of Figures

  • Figure 1: Global: Microcarrier Market: Major Drivers and Challenges
  • Figure 2: Global: Microcarrier Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Microcarrier Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Microcarrier Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Microcarrier Market: Breakup by Material Type (in %), 2023
  • Figure 6: Global: Microcarrier Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Microcarrier Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Microcarrier Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Microcarrier (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Microcarrier (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Microcarrier (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Microcarrier (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Microcarrier (Alginate-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Microcarrier (Alginate-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Microcarrier (Collagen-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Microcarrier (Collagen-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Microcarrier (Dextran-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Microcarrier (Dextran-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Microcarrier (Polystyrene-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Microcarrier (Polystyrene-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Microcarrier (Other Material Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Microcarrier (Other Material Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Microcarrier (Vaccine Manufacturing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Microcarrier (Vaccine Manufacturing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Microcarrier (Cell Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Microcarrier (Cell Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Microcarrier (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Microcarrier (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Microcarrier (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Microcarrier (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Microcarrier (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Microcarrier (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Microcarrier (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Microcarrier (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Microcarrier (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Microcarrier (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Microcarrier Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Microcarrier Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Microcarrier Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Microcarrier Industry: SWOT Analysis
  • Figure 87: Global: Microcarrier Industry: Value Chain Analysis
  • Figure 88: Global: Microcarrier Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Microcarrier Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Microcarrier Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Microcarrier Market Forecast: Breakup by Material Type (in Million US$), 2024-2032
  • Table 4: Global: Microcarrier Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Microcarrier Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Microcarrier Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Microcarrier Market: Competitive Structure
  • Table 8: Global: Microcarrier Market: Key Players
目次
Product Code: SR112024A4537

The global microcarrier market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The global market is primarily driven by the rising demand for biopharmaceuticals, continual advancements in cell-based therapies, expanding stem cell research, ongoing technological innovations in carrier design, and substantial investments in biomanufacturing infrastructure.

Microcarrier Market Analysis:

  • Market Growth and Size: The global market has been experiencing robust growth, driven by the increasing demand for biopharmaceuticals and cell-based therapies, resulting in a significant market size.
  • Major Market Drivers: The primary drivers include the increasing demand for biopharmaceuticals, advancements in cell-based therapies, and expanding stem cell research.
  • Technological Advancements: Emerging innovations in the design and manufacturing techniques have led to improved surface properties, size, and shape, enhancing cell culture processes, and reducing production costs.
  • Industry Applications: They find extensive applications in vaccine manufacturing and cell therapy, supporting the growth of these crucial segments in the biopharmaceutical industry.
  • Key Market Trends: Key trends include the adoption of single-use technologies in biomanufacturing, the emergence of Asia Pacific as a biopharmaceutical hub, and the preference for alginate-based variants due to their adaptability.
  • Geographical Trends: North America remains the largest market due to its established biopharmaceutical industry, while the Asia Pacific region is experiencing rapid growth with investments in biotechnology infrastructure.
  • Competitive Landscape: Key players are investing in R&D, expanding production capacity, forming strategic partnerships, and focusing on regulatory compliance to stay competitive in the market.
  • Challenges and Opportunities: Challenges include regulatory complexities and the need for consistent quality control. Opportunities lie in the growing global demand for biopharmaceuticals and the expansion of biomanufacturing infrastructure.

Microcarrier Market Trends:

Growing demand for biopharmaceuticals

Biopharmaceuticals have gained prominence due to their effectiveness in treating various diseases, and they play a pivotal role in the production of these biotherapeutics. As the pharmaceutical industry continues to shift towards biologics and personalized medicine, the demand for micro-carriers as a substrate for cell culture in bioprocessing is expected to increase. This factor is driven by the need for scalable and efficient cell expansion and cultivation processes, which carriers facilitate. The ongoing research and development efforts in the biopharmaceutical sector, coupled with the expansion of biomanufacturing facilities, are contributing to the sustained growth of the market. Moreover, the COVID-19 pandemic has further accelerated the demand for vaccines and therapeutic proteins, emphasizing the crucial role in bioproduction.

Advancements in cell-based therapies

The rapid advancements in cell-based therapies, particularly in regenerative medicine and immunotherapy, are fueling the growth of the market. These therapies involve the culturing and expansion of patient-derived cells or immune cells, which necessitates the use of as a support matrix for cell growth. The increasing focus on personalized medicine and the development of innovative treatments for conditions such as cancer, autoimmune diseases, and tissue regeneration have led to a rise in the demand. Additionally, the flexibility, scalability, and reproducibility offered by cell culture systems make them indispensable in the manufacturing of cell therapies, thus creating appositive market outlook.

Expansion of stem cell research

Stem cell research continues to be a dynamic and promising field with applications in both basic research and clinical applications. They are widely utilized for the expansion of stem cells, whether for studying developmental processes or for therapeutic purposes. In addition to this, the increasing investment in stem cell research, coupled with the rising interest in regenerative medicine, is propelling the market across the globe. Researchers and biotechnology companies rely on microcarriers to provide a controlled environment for the growth and differentiation of stem cells, which is essential for the development of cell-based therapies and tissue engineering.

Microcarrier Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, material type, application, and end user.

Breakup by Product:

  • Equipment
    • Bioreactors
    • Culture Vessels
    • Filtration Systems
    • Cell Counters
    • Accessories
  • Consumables
    • Media
    • Reagents
    • Microcarrier Beads

Consumables accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes equipment (bioreactors, culture vessels, filtration systems, cell counters, accessories), and consumables (media, reagents and microcarrier beads). According to the report, consumables represented the largest segment.

The equipment segment of the market encompasses various instruments and machines used in cell culture processes. This includes bioreactors, fermenters, and cell culture systems that facilitate the growth and expansion of cells attached to micro-carriers. These equipment pieces play a vital role in ensuring a controlled and sterile environment for cell culture. Biopharmaceutical manufacturers and research institutions heavily invest in advanced equipment to enhance productivity and scalability. As the bioprocessing industry continues to grow, augmenting by the demand for biopharmaceuticals, the equipment segment is witnessing steady expansion.

On the other hand, the consumables segment is the largest and most critical part of the market. It comprises various consumable items used in cell culture, such as micro-carriers themselves, culture media, reagents, and disposables. They are the primary component of this segment, serving as the substrate for cell attachment and growth. The consumables segment is driven by the constant need for high-quality, sterile, and scalable materials for bioprocessing applications.

Breakup by Material Type:

  • Alginate-based
  • Collagen-based
  • Dextran-based
  • Polystyrene-based
  • Others

Alginate-based holds the largest share in the industry

A detailed breakup and analysis of the market based on the material type have also been provided in the report. This includes alginate-based, collagen-based, dextran-based, polystyrene-based, and others. According to the report, alginate-based accounted for the largest market share.

The alginate-based segment holds a dominant position in the market due to its versatility and widespread use. Alginate is a biocompatible polymer derived from seaweed, making it an attractive choice for cell culture applications. These carriers provide a suitable environment for the growth of various cell types and are particularly popular in the biopharmaceutical and regenerative medicine industries. Alginate-based variants offer excellent cell attachment properties and can be easily customized to support different cell cultures, contributing to their leading market share.

On the other hand, collagen is a natural protein found in the extracellular matrix, making it highly biocompatible and suitable for cell attachment and growth. They are commonly used in tissue engineering and regenerative medicine applications, as they mimic the native tissue environment. Collagen-based type promote cell adhesion and proliferation, making them valuable for culturing cells for therapeutic purposes.

Moreover, dextran-based variants are known for their hydrophilic properties and are often chosen for specialized cell culture needs. Dextran is a polysaccharide that can be modified to control the surface properties, making them suitable for specific cell types or research objectives. They cater to niche applications where precise control over the cell culture environment is essential.

Additionally, polystyrene-based carriers are characterized by their inert and non-biodegradable nature. They are commonly employed in traditional adherent cell culture systems. They are known for their consistency and ease of use, making them a preferred choice in certain bioprocessing applications. They have a place in the market, particularly for well-established cell lines and processes.

Breakup by Application:

  • Vaccine Manufacturing
  • Cell Therapy
  • Others

Vaccine manufacturing represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes vaccine manufacturing, cell therapy and others. According to the report, vaccine manufacturing represented the largest segment.

Vaccine manufacturing is the dominant segment in the market, driven by the critical role of in the production of vaccines. They serve as a platform for the cultivation of virus-infected cells or cells expressing vaccine antigens. They provide a controlled environment for the growth of these cells, allowing for efficient virus replication or antigen expression. With the increasing global demand for vaccines, especially in response to pandemics and emerging infectious diseases, the vaccine manufacturing segment is witnessing substantial growth. These carriers enable scalable and high-yield vaccine production, ensuring a steady supply to meet healthcare needs worldwide.

On the contrary, the cell therapy involves the expansion and manipulation of patient-derived cells for therapeutic purposes, such as cancer immunotherapy and regenerative medicine. They play a pivotal role in the large-scale expansion of these cells in bioreactors, providing a suitable surface for cell adhesion and growth. As cell therapies continue to gain traction in the healthcare industry, the demand in this segment is on the rise.

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs), and others. According to the report, pharmaceutical and biotechnology companies for the largest market share.

Pharmaceutical companies are the largest end-user segment in the market, primarily due to their extensive involvement in biopharmaceutical production. These companies rely on micro-carriers for the scalable and efficient cultivation of cells used in the manufacturing of biologics, including monoclonal antibodies, vaccines, and therapeutic proteins. They provide a controlled environment for cell growth, ensuring high yields and consistent product quality. As the demand for biopharmaceuticals continues to grow worldwide, pharmaceutical companies are continually expanding their biomanufacturing capacity, driving the demand.

On the other hand, academic and research institutes are centers of basic and applied research, contributing to the advancement of scientific knowledge and innovation. They often require market research to understand industry trends, secure funding, and collaborate effectively with the private sector. Market research for these institutions is frequently centered around emerging technologies, intellectual property landscapes, and potential commercialization pathways.

Additionally, contract research organizations are specialized companies that provide support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. This segment, while smaller compared to pharmaceutical and biotechnology companies, is vital due to its role in expediting drug development and clinical trials.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest microcarrier market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America stands as the largest segment in the market, driven by the presence of a well-established biopharmaceutical industry and advanced biomanufacturing facilities. The United States hosts numerous pharmaceutical and biotechnology companies that heavily rely on these carriers for large-scale cell culture processes. The region's commitment to research and development, along with a robust healthcare infrastructure, further fuels the demand for biopharmaceuticals and microcarrier. Regulatory support and technological advancements in the bioprocessing sector also contribute to North America's leadership in the market.

On the contrary, the Asia Pacific region increasingly focus on producing biopharmaceuticals and expanding their healthcare infrastructure. The region's competitive advantage lies in cost-effective production, making it an attractive destination for outsourcing biopharmaceutical manufacturing services. Asia Pacific's contribution to the market is growing steadily, reflecting its emergence as a global hub for biotechnology and biomanufacturing.

Furthermore, Europe is a prominent segment in the market, characterized by a strong pharmaceutical industry and a history of innovation in bioprocessing. Countries have established themselves as key players in biopharmaceutical production. European pharmaceutical and biotechnology companies adopt carriers to ensure efficient and high-yield cell culture processes. Additionally, academic and research institutes in Europe contribute to advancements in cell culture technology.

Additionally, Latin America represents a growing segment in the market, driven by the increasing interest in biopharmaceutical production and research activities. Countries such as Brazil and Mexico are witnessing investments in biotechnology and biomanufacturing infrastructure. They play a crucial role in supporting the region's efforts to expand its biopharmaceutical capabilities.

Moreover, the Middle East and Africa are emerging segments in the market, with a focus on developing healthcare infrastructure and expanding biopharmaceutical capabilities. Countries, such as the United Arab Emirates are investing in biotechnology and research, augmenting the adoption for cell culture processes. It holds potential for growth in the coming years as the region seeks to establish itself in the biopharmaceutical industry.

Leading Key Players in the Microcarrier Industry:

The key players in the global market are actively engaged in several strategic initiatives to maintain their competitive edge. These initiatives include continuous research and development to improve the design, materials, and performance. Many are investing in expanding production capacity to meet the growing demand for biopharmaceuticals and cell therapies. Additionally, key players are entering partnerships and collaborations with pharmaceutical companies, biotech firms, and research institutions to jointly develop innovative solutions and applications. Various companies are also focusing on regulatory compliance and quality control measures to ensure the highest standards in bioprocessing.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • CESCO Bioengineering Co. Ltd.
  • ChemoMetec A/S
  • Corning Incorporated
  • Cytiva (Danaher Corporation)
  • Eppendorf AG
  • Esco VacciXcell
  • HiMedia Laboratories
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • VWR International LLC (Avantor Inc.)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • 04 January 2024: Thermo Fisher Scientific Inc. launched PangenomiX array to support population-scale disease studies and pharmacogenomics research. The PangenomiX Array uniquely integrates four assays into one, enabling SNP genotyping, copy number variant detection, fixed copy number discovery, blood and HLA typing.
  • 20 October 2023: Eppendorf AG have launched the Mastercycler(R) X40, a high-quality thermal cycler. The Mastercycler X40 enhances PCR with its user-friendly interface, versatile tube and plate compatibility, sample protection, temperature optimization, and efficient program migration.
  • 16 October 2023: Lonza Group AG and Vaxcyte expand collaboration for global commercial manufacturing of broad-spectrum pneumococcal conjugate vaccines (PCVs). This agreement complements Vaxcyte's plans to utilize existing Lonza infrastructure to advance clinical development and the anticipated initial U.S. launch of VAX-24 for the adult population.

Key Questions Answered in This Report:

  • How has the global microcarrier market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global microcarrier market?
  • What is the impact of each driver, restraint, and opportunity on the global microcarrier market?
  • What are the key regional markets?
  • Which countries represent the most attractive microcarrier market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the microcarrier market?
  • What is the breakup of the market based on the material type?
  • Which is the most attractive material type in the microcarrier market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the microcarrier market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the microcarrier market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global microcarrier market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Microcarrier Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bioreactors
      • 6.1.2.2 Culture Vessels
      • 6.1.2.3 Filtration Systems
      • 6.1.2.4 Cell Counters
      • 6.1.2.5 Accessories
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Media
      • 6.2.2.2 Reagents
      • 6.2.2.3 Microcarrier Beads
    • 6.2.3 Market Forecast

7 Market Breakup by Material Type

  • 7.1 Alginate-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Collagen-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dextran-based
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polystyrene-based
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Vaccine Manufacturing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cell Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CESCO Bioengineering Co. Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 ChemoMetec A/S
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Corning Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cytiva (Danaher Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eppendorf AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Esco VacciXcell
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 HiMedia Laboratories
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Lonza Group AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sartorius AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 VWR International LLC (Avantor Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio